| Literature DB >> 29805492 |
Yun Wang1, Haiyan Xu1, Haiyan Li2, Yan Liu3, Qingling Bai4.
Abstract
In the present study we aimed to analyze the effects of different anesthesia methods on the hemodynamics of caesarean section, outcomes after caesarean section and hormone changes in pregnancy complicated with severe pulmonary arterial hypertension (PAH). A total of 75 pregnancy complicated with severe PAH that were treated in Jining First People's Hospital from January 2016 to January 2017 were selected. Three groups were set according to the anesthesia methods, including the subarachnoid combined epidural anesthesia group (group I, n=25), the epidural anesthesia group (group II, n=25) and the general anesthesia group (group III, n=25). Effects on the outcomes of caesarean section of pregnancy complicated with PAH were observed. Sex hormone levels before and 24, 48 and 72 h after the operation were measured. There were remarkable changes in the postoperative hemodynamics compared with those before anesthesia, but changes in groups I and II were significantly smaller than those in group III (P<0.05). No significant differences in maternal mortality rate, neonatal mortality rate and neonatal asphyxia rate among the three groups were found (P>0.05). Time of postoperative mechanical ventilation, ICU residence and hospitalization in groups I and II were shorter than those in group III, the differences were statistically significant (P<0.05). Postoperative levels of sex hormones, including estradiol (E2), human chorionic gonadotrophin (HCG), prolactin (PRL) and plasma total testosterone (TT) decreased, while postoperative levels of sex hormones follicle stimulating hormone (FSH), luteinizing hormone (LH) and progestogen increased, and differences in the decreased E2 and TT at each time-point were statistically significant (P<0.05). In conclusion, there is no remarkable difference in the effects of three anesthesia methods on pregnancy outcomes. However, compared with general anesthesia, intravertebral anesthesia achieve shorter time of postoperative mechanical ventilation, ICU residence and hospitalization in pregnancy complicated with severe PAH, which is preferred in pregnancy without contraindication of the anesthesia.Entities:
Keywords: different anesthesia methods; hemodynamics; hormones; outcomes; pregnancy with severe PAH
Year: 2018 PMID: 29805492 PMCID: PMC5952086 DOI: 10.3892/etm.2018.5996
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Comparisons of general clinical data among the three groups of puerperae.
| Items | Group I (n=25) | Group II (n=25) | Group III (n=25) |
|---|---|---|---|
| Age (years) | 28.11±4.01 | 27.58±4.92 | 27.88±4.24 |
| Weight (kg) | 60.22±3.38 | 60.77±3.45 | 59.58±4.43 |
| Gestational age (weeks) | 30.38±4.98 | 30.78±4.02 | 30.44±4.35 |
| Primiparity, n (%) | 20 (80.00) | 21 (84.00) | 19 (76.00) |
| Cardiac function grading | |||
| Grade III | 14 (56.00) | 13 (52.00) | 14 (56.00) |
| Grade IV | 10 (40.00) | 12 (48.00) | 11 (44.00) |
| Type of cardiac disease, n (%) | |||
| Congenital heart disease | 15 (60.00) | 13 (52.00) | 14 (56.00) |
| Rheumatic heart disease | 10 (40.00) | 12 (48.00) | 11 (44.00) |
| Complication, n (%) | |||
| Arrhythmia | 13 (52.00) | 7 (58.33) | 9 (60.00) |
| Hypoproteinemia | 19 (76.00) | 10 (83.33) | 12 (80.00) |
| Pulmonary infection | 8 (32.00) | 9 (36.00) | 7 (28.00) |
Comparisons of hemodynamic changes at different time-points among the three groups of patients (n=25).
| Groups | Systolic blood pressure | Δ Systolic blood pressure | Diastolic blood pressure | Δ Diastolic blood pressure | Blood oxygen saturation | Δ Blood oxygen saturation |
|---|---|---|---|---|---|---|
| T0 | ||||||
| I | 154.22±15.32 | 90.12±6.38 | 90.02±6.98 | |||
| II | 151.45±16.52 | 89.91±6.65 | 89.98±5.83 | |||
| III | 156.70±15.88 | 88.00±8.02 | 89.02±6.78 | |||
| T1 | ||||||
| I | 136.70±8.97[ | 16.41±6.65[ | 84.91±4.10[ | 4.28±1.39[ | 91.88±3.43[ | 3.22±1.73[ |
| II | 131.12±8.28[ | 21.79±7.01[ | 81.77±4.98[ | 7.02±2.03[ | 92.25±3.93[ | 3.03±1.92[ |
| III | 123.68±9.10[ | 31.35±5.61 | 77.33±5.05[ | 7.98±3.05 | 95.22±4.11[ | 8.02±1.98 |
| T2 | ||||||
| I | 127.72±7.18[ | 28.03±5.00[ | 79.19±6.52[ | 8.79±2.88[ | 93.92±3.48[ | 5.04±2.22[ |
| II | 119.88±8.05[ | 31.49±4.98[ | 76.48±4.50[ | 11.77±1.28[ | 94.77±2.56[ | 5.62±3.10[ |
| III | 113.12±12.33[ | 43.35±6.77 | 73.15±4.98[ | 13.88±2.70 | 97.12±4.48[ | 9.78±2.68 |
Comparison with that at T0
comparison with that in group III
comparison with that in group II; P<0.05 suggests that the difference is statistically significant.
Comparison of hospitalization after the operation among the three groups of pregnant patients (mean ± SD).
| Groups | No. | Postoperative hospital stay | ICU staying time | Time of mechanical ventilation |
|---|---|---|---|---|
| I | 25 | 8.16±2.53[ | 3.35±2.10[ | 2.01±1.16[ |
| II | 25 | 8.77±2.28[ | 4.01±1.78[ | 2.15±1.38[ |
| III | 25 | 15.88±9.45 | 7.99±5.87 | 5.66±4.23 |
P<0.05 compared with group III.
Comparisons of pregnancy outcomes among the three groups of pregnant patients, n (%).
| Groups | No. | Neonatal death | Neonatal asphyxia | Maternal death |
|---|---|---|---|---|
| I | 25 | 1 (4.0) | 3 (12.0) | 0 (0.0) |
| II | 25 | 0 (0.0) | 3 (12.0) | 1 (4.0) |
| III | 25 | 0 (0.0) | 4 (16.0) | 1 (4.0) |
Comparisons of sex hormone levels at different time-points among the three groups of patients (mean ± SD, ng/l).
| Groups | Time | E2 | TT | HCG | FSH | LH | PROG | PRL |
|---|---|---|---|---|---|---|---|---|
| I (n=25) | Before operation | 36.18±8.88 | 3880.09±1100.64 | 5.64±3.77 | 3.11±1.33 | 23.16±12.58 | 761.12±348.21 | 522.22±218.66 |
| At the end of operation | 30.12±9.01[ | 3011.18±1313.46[ | 5.33±3.45 | 3.50±1.79 | 22.78±12.68 | 860.12±328.23 | 400.00±221.66 | |
| 24 h after operation | 26.25±9.88[ | 3077.45±1200.45[ | 4.48±1.39 | 4.30±2.20 | 25.00±12.35 | 940.13±209.98 | 459.33±155.65 | |
| 48 h after operation | 24.15±9.12[ | 2244.33±1225.38[ | 5.09±3.11 | 5.31±2.98 | 27.02±14.58 | 1000.88±320.23 | 420.26±166.85 | |
| 72 h after operation | 22.23±7.78[ | 1798.66±1235.16[ | 3.44±1.55 | 5.54±3.03 | 32.12±7.56 | 1030.11±300.88 | 330.36.±188.10 | |
| II (n=25) | Before operation | 37.16±9.18 | 3900.09±1157.64 | 5.99±4.01 | 3.07±1.28 | 23.77±13.59 | 770.12±355.23 | 530.22±228.78 |
| At the end of operation | 29.02±9.48[ | 3065.18±1399.76[ | 5.58±3.66 | 3.69±1.86 | 22.48±13.87 | 880.15±340.15 | 410.23±210.12 | |
| 24 h after operation | 27.45±10.11[ | 3100.55±1251.75[ | 4.39±1.56 | 4.45±2.28 | 25.56±13.38 | 960.54±218.40 | 470.54±133.32 | |
| 48 h after operation | 25.77±9.00[ | 2299.47±1289.44[ | 5.14±3.47 | 5.55±3.10 | 27.76±15.66 | 1010.28±312.18 | 441.23±160.88 | |
| 72 h after operation | 23.17±6.68[ | 1818.87±1300.15[ | 3.28±1.35 | 5.36±3.18 | 31.23±7.15 | 1040.63±308.07 | 350.11±178.99 | |
| III (n=25) | Before operation | 35.12±14.13 | 3988.10±1173.54 | 5.88±3.97 | 2.98±1.13 | 22.98±13.47 | 793.48±370.45 | 543.38±238.13 |
| At the end of operation | 26.52±10.48[ | 3059.46±1333.45[ | 5.42±3.43 | 3.65±1.73 | 23.03±14.48 | 890.35±338.25 | 399.13±158.43 | |
| 24 h after operation | 24.36±9.77[ | 3120.48±1322.35[ | 4.25±1.37 | 4.40±2.15 | 28.35±13.32 | 978.43±223.40 | 480.02±122.14 | |
| 48 h after operation | 20.18±8.96[ | 2335.40±1310.46[ | 5.03±3.54 | 5.12±2.91 | 28.03±13.65 | 1040.44±310.11 | 428.12±180.44 | |
| 72 h after operation | 16.33±4.89[ | 1799.93±1388.51[ | 3.18±1.33 | 5.28±3.13 | 33.12±7.99 | 1069.87±298.89 | 298.15±203.20 |
Compared with that at each time-point before the operation within groups, P<0.05
intergroup comparison at the time-point, P<0.05.
Correlation analysis of serum inflammatory factors and pulmonary functions in case of pregnancy complicated with severe PAH (r value).
| Relevant variable | TT | E2 | HCG | PRL | FSH | LH | PROG |
|---|---|---|---|---|---|---|---|
| Systolic blood pressure | −1.010[ | −0.792[ | −0.170 | −0.313 | −0.412 | −0.312 | −0.189 |
| Diastolic blood pressure | −0.811[ | −0.688[ | −0.179 | −0.289 | −0.403 | −0.303 | −0.221 |
TT, total testosterone; E2, estradiol; FSH, follicle stimulating hormone; LH, luteinizing hormone; PROG, progestogen; HCG, human chorionic gonadotrophin; PRL, prolactin.
Significant correlationship.